Overview

This is a prospective, non-interventional, observational study. The purpose of this study is to collect data and bio-specimens that will support future research

Eligibility

Inclusion Criteria:

1. Male or female patients ≥ 18 years of age at the time of informed consent
2. Has been diagnosed with or is suspected to have one of the following:
   1. Monoclonal Gammopathy of Undetermined Significance (MGUS)
   2. Smoldering Multiple Myeloma
   3. Multiple Myeloma
   4. Bony or Soft Tissue Plasmacytoma
   5. Primary Amyloidosis

Exclusion Criteria:

< 18 years of age

Have not been diagnosed with one of the following:

        Monoclonal Gammopathy of Undetermined Significance (MGUS) b.Smoldering Multiple Myeloma
        c.Multiple Myeloma d.Bony or Soft Tissue Plasmacytoma e.Primary Amyloidosis